MA30692B1 - Composition pharmaceutique contenant le bicalutamide et procede de son utilisation - Google Patents

Composition pharmaceutique contenant le bicalutamide et procede de son utilisation

Info

Publication number
MA30692B1
MA30692B1 MA31598A MA31598A MA30692B1 MA 30692 B1 MA30692 B1 MA 30692B1 MA 31598 A MA31598 A MA 31598A MA 31598 A MA31598 A MA 31598A MA 30692 B1 MA30692 B1 MA 30692B1
Authority
MA
Morocco
Prior art keywords
composition
bicalutamide
pharmaceutical composition
composition containing
mammal
Prior art date
Application number
MA31598A
Other languages
English (en)
French (fr)
Inventor
Amarjit Singh
Sarabjit Singh
Shivanand Puthli
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of MA30692B1 publication Critical patent/MA30692B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA31598A 2006-07-07 2009-01-30 Composition pharmaceutique contenant le bicalutamide et procede de son utilisation MA30692B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1074MU2006 2006-07-07

Publications (1)

Publication Number Publication Date
MA30692B1 true MA30692B1 (fr) 2009-09-01

Family

ID=39492731

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31598A MA30692B1 (fr) 2006-07-07 2009-01-30 Composition pharmaceutique contenant le bicalutamide et procede de son utilisation

Country Status (16)

Country Link
US (1) US20090317464A1 (ja)
EP (1) EP2046321A4 (ja)
JP (1) JP2009542627A (ja)
KR (1) KR20090057214A (ja)
CN (1) CN101478963A (ja)
AR (1) AR061853A1 (ja)
BR (1) BRPI0714053A2 (ja)
CA (1) CA2655541A1 (ja)
CO (1) CO6150137A2 (ja)
EA (1) EA200970097A1 (ja)
MA (1) MA30692B1 (ja)
MX (1) MX2009000268A (ja)
TN (1) TNSN08530A1 (ja)
UA (1) UA92233C2 (ja)
WO (1) WO2008068770A2 (ja)
ZA (1) ZA200900502B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103860487B (zh) * 2012-12-10 2016-07-06 天津市汉康医药生物技术有限公司 一种比卡鲁胺片及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
JP2005060302A (ja) * 2003-08-12 2005-03-10 Sumitomo Chemical Co Ltd Ｎ−メタクリロイル−４−シアノ−３−トリフルオロメチルアニリンの製造方法および安定化方法
US20060269596A1 (en) * 2005-01-12 2006-11-30 Gary Liversidge Controlled release compositions comprising an acylanilide

Also Published As

Publication number Publication date
KR20090057214A (ko) 2009-06-04
WO2008068770A3 (en) 2008-10-16
ZA200900502B (en) 2010-06-30
JP2009542627A (ja) 2009-12-03
TNSN08530A1 (en) 2010-04-14
BRPI0714053A2 (pt) 2012-12-18
EP2046321A4 (en) 2011-08-31
EA200970097A1 (ru) 2009-06-30
CO6150137A2 (es) 2010-04-20
WO2008068770A2 (en) 2008-06-12
AR061853A1 (es) 2008-09-24
MX2009000268A (es) 2009-01-26
EP2046321A2 (en) 2009-04-15
CN101478963A (zh) 2009-07-08
US20090317464A1 (en) 2009-12-24
CA2655541A1 (en) 2008-06-12
UA92233C2 (ru) 2010-10-11

Similar Documents

Publication Publication Date Title
Lord et al. Pharmacology of a novel central nervous system–penetrant P2X7 antagonist JNJ-42253432
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
Benson et al. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models
MA33044B1 (fr) Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient
MX355482B (es) Anticuerpo anti - adrenomedulina (adm) o fragmento de anticuerpo anti - adm o un andamio no ig anti - adm para usarse en terapia.
MY178654A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig protein scaffold for use in therapy
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
MX2009005398A (es) Metodos para el tratamiento de enfermedades inflamatorias cronicas usando antagonista de gm-csf.
MY160074A (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
EA201170330A1 (ru) Фармацевтические композиции и их введение
NZ598732A (en) Dosage regimen for administering a cd19xcd3 bispecific antibody
TN2012000270A1 (en) Methods and low dose regimens for treating red blood cell disorders
MX2023008408A (es) Composiciones antisentido, y metodos para obtener y usar las mismas.
SG157379A1 (en) Hydroxybenzoate salts of metanicotine compounds
EA201100896A1 (ru) Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение
NZ606825A (en) Methods and compositions for treating complement-associated disorders
EP2493507A4 (en) ANTAGONISTS AND VARIANTS AX213 AND AX132 PCSK9
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
EA201200519A1 (ru) Стабилизированные жидкие и лиофилизированные композиции adamts13
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
PH12017502049A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2014001088A (es) Ciertos inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas, y metodos de uso de las mismas.
PH12014501620A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
MX2021002322A (es) Nuevos metodos.